ACB Earnings Preview: Options Price a ±15.5% Move

· The NYC Memo · ACB reports 2026-11-04

Aurora Cannabis Inc. reports November 4, 2026. The January 15, 2027 straddle implies ±15.50% against a 15.53% average reaction, with dealers long gamma and max pain at $4.

Live updates

Nov 4 — Ahead of ACB earnings on November 4, 2026, the implied move narrowed from ±18.01% to ±15.50% as spot rose from $4.22 to $5.16 and implied volatility fell from 44.8% to 41.9%, implying reduced expectations for post-earnings price volatility.

Nov 3 — Ahead of November 4, 2026 earnings, ACB rose from $4.06 to $4.22 as at-the-money implied volatility fell from 48.1% to 44.8%, compressing the implied move from ±19.70% to ±18.01% and signaling expectations for a narrower post-earnings price reaction.

Aurora Cannabis Inc. (ACB) reports on November 4, 2026, with spot at $5.16. Shares sit -18.9% from their 52-week high after gaining +15.7% over the past month. For the January 15, 2027 expiry, the $0.80 straddle implies a 15.50% move, spanning $4.36 to $5.96 with atm iv at 41.9%. That pricing mirrors the average realised reaction of 15.53% across 4 prints counted, which split 2 higher and 2 lower.

Positioning features a put_call_oi of 0.53 and max_pain at $4. A dealer lean of long gamma means market makers must sell into strength and buy into weakness. This inventory structure should cushion price swings and steady the tape into the print.

What the market will be watching

The desk enters Aurora Cannabis earnings focused on medical market stability against recreational sales softness. Options flow will react primarily to international medical export strength and gross margin performance, which signal whether previous facility rationalization continues to protect profits. Cost controls remain critical as traders look for reduced cash burn across production facilities. Management commentary regarding forward guidance must show a clear route toward sustainable positive free cash flow for the remainder of the year. Desk positioning will also swing on international regulatory milestones and export licensing updates.

What the options market is pricing

MeasureLevel
PrintNovember 4, 2026
Expiry usedJanuary 15, 2027 (72 days out)
Spot$5.16
ATM straddle$0.80
Implied move±15.50% ($4.36 to $5.96)
ATM implied vol41.9%
Put/call open interest0.53
Max pain$4
Net dealer gamma+$0.04mn per 1% move, LONG GAMMA
Heaviest call strike above spot$10 (1,699 contracts)
Heaviest put strike below spot$3 (2,580 contracts)

Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ACB between catalysts. That damping disappears the moment the number crosses the tape.

How the stock has reacted before

ReportNext-day move
Q2 2026, Aug 10+16.56%
Q1 2026, Apr 22-7.87%
Q4 2025, Feb 4-18.47%
Q3 2025, Dec 11+19.21%

Across the last 4 prints the average absolute reaction is 15.53%, with 2 higher and 2 lower. The best was +19.21% and the worst -18.47%. Options are asking ±15.50%, which is 0.03 points cheaper than the realised average, the premium buyer's case.

Where the stock is trading

MeasureLevel
Spot$5.16
52-week range$2.56 to $6.36
Position in that range68%
From the 52-week high-18.9%
From the 52-week low+101.6%
Past week+24.3%
Past month+15.7%
Past three months+77.3%
50-day average$4.07
200-day average$3.55

How the options market is pricing it

The January 15, 2027 straddle marks $4.36 to $5.96 as the range the options market is paying for into the print, with ATM implied vol at 42% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ACB has moved 15.53% on earnings against the ±15.50% now implied, so the market is pricing this print cheaper than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.

Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ACB before the print.

Data as of November 4, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.

Related: ACB options memo

More earnings previews